Topic | Item | Checklist item description | Reported on |
---|---|---|---|
Title | 1 | The diagnosis or intervention of primary focus followed by the words “case report | Title |
Key words | 2 | 2 to 5 key words that identify diagnoses or interventions in this case report, including "case report" | Keywords |
Abstract | 3a | Introduction: What is unique about this case and what does it add to the scientific literature? | Abstract, P1 |
3b | Main symptoms and/or important clinical findings | Abstract, P2 | |
3c | The main diagnoses, therapeutic interventions, and outcomes | Abstract, P2-3 | |
3d | Conclusion—What is the main “take-away” lesson(s) from this case? | Abstract, P4 | |
Introduction | 4 | One or two paragraphs summarizing why this case is unique (may include references) | Background, P8 |
Patient Information | 5a | De-identified patient specific information | Case present., P1 |
5b | Primary concerns and symptoms of the patient | Case present., P1 | |
5c | Medical, family, and psycho-social history including relevant genetic information | Case present., P1 | |
5d | Relevant past interventions with outcomes | Case present., P1 | |
Clinical Findings | 6 | Describe significant physical examination (PE) and important clinical findings | Case present., P1-2 |
Timeline | 7 | Historical and current information from this episode of care organized as a timeline | Table 1 |
Diagnostic Assessment | 8a | Diagnostic testing (such as PE, laboratory testing, imaging, surveys) | Case present., P3-7 |
8b | Diagnostic challenges (such as access to testing, financial, or cultural) | N/A | |
8c | Diagnosis (including other diagnoses considered) | Case present., P6 | |
8d | Prognosis (such as staging in oncology) where applicable | Discussion, P9 | |
Therapeutic Intervention | 9a | Types of therapeutic intervention (such as pharmacologic, surgical, preventive, self-care) | Case present., P9 |
9b | Administration of therapeutic intervention (such as dosage, strength, duration) | N/A | |
9c | Changes in therapeutic intervention (with rationale) | N/A | |
Follow-up and Outcomes | 10a | Clinician and patient-assessed outcomes (if available) | Case present., P9-10 |
10b | Important follow-up diagnostic and other test results | Case present., P10 | |
10c | Intervention adherence and tolerability (How was this assessed?) | N/A | |
10d | Adverse and unanticipated events | Case present., P9-10 | |
Discussion | 11a | A scientific discussion of the strengths AND limitations associated with this case report | Discussion, P1-9 |
11b | Discussion of the relevant medical literature with references | Discussion, P1-9 | |
11c | The scientific rationale for any conclusions (including assessment of possible causes) | Conclusions | |
11d | The primary “take-away” lessons of this case report (without references) in a one paragraph conclusion | Conclusions | |
Patient Perspective | 12 | The patient should share their perspective in one to two paragraphs on the treatment(s) they received | N/A |
Informed Consent | 13 | Did the patient give informed consent? Please provide if requested | Yes |